首页 > 最新文献

Preventing Chronic Disease最新文献

英文 中文
The National and State Tobacco Control Program: Overview of the Centers for Disease Control and Prevention's Efforts to Address Commercial Tobacco Use. 国家和州烟草控制计划:疾病控制和预防中心解决商业烟草使用问题的工作概述。
IF 5.5 3区 医学 Q1 Medicine Pub Date : 2024-05-30 DOI: 10.5888/pcd21.230311
LaTisha Marshall, Emilia Pasalic, Margaret Mahoney, Tiffany Turner, Karla Sneegas, Deirdre Lawrence Kittner
{"title":"The National and State Tobacco Control Program: Overview of the Centers for Disease Control and Prevention's Efforts to Address Commercial Tobacco Use.","authors":"LaTisha Marshall, Emilia Pasalic, Margaret Mahoney, Tiffany Turner, Karla Sneegas, Deirdre Lawrence Kittner","doi":"10.5888/pcd21.230311","DOIUrl":"10.5888/pcd21.230311","url":null,"abstract":"","PeriodicalId":51273,"journal":{"name":"Preventing Chronic Disease","volume":null,"pages":null},"PeriodicalIF":5.5,"publicationDate":"2024-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11155683/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141181489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Strategies for Effective Capacity-Building in the Fight Against Commercial Tobacco. 打击商业烟草的有效能力建设战略。
IF 4.4 3区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-05-23 DOI: 10.5888/pcd21.230307
Kimberly Caldwell, Ashley Hebert, Gregory Bolden

The Center for Black Health & Equity's approach to addressing health inequities relies on the inherent ability within community-based organizations to respond to public health priorities while addressing the political and social determinants of health. By using Dr. Robert Robinson's Community Development Model as a foundational framework, communities can address systemic barriers that impede optimal health outcomes. The model includes community engagement and mobilization activities that motivate communities to achieve equity-centered policy change and offers milestones that show progress made toward their goals and objectives. We operationalized the Community Development Model into the Community Capacity Building Curriculum to train community partners to form a multicultural coalition through asset mapping as a tool for community mobilization. This curriculum is both cost effective and efficient because it enables communities to address health disparities beyond tobacco control, such as food and nutrition, housing, and environmental issues. Coalitions are prepared to identify and make recommendations to address policies that perpetuate health disparities. Facing off against a powerful tobacco industry giant is challenging for small grassroots organizations advocating for stricter tobacco regulations and policies. Such organizations struggle for resources; however, their passion and dedication to the mission of saving Black lives can promote change.

黑人健康与公平中心(Center for Black Health & Equity)解决健康不公平问题的方法依赖于社区组织在解决健康的政治和社会决定因素的同时响应公共卫生优先事项的内在能力。通过使用罗伯特-罗宾逊博士的社区发展模式作为基础框架,社区可以解决阻碍最佳健康结果的系统性障碍。该模式包括社区参与和动员活动,以激励社区实现以公平为中心的政策变革,并提供里程碑,显示在实现其目标和目的方面取得的进展。我们将社区发展模式运用到社区能力建设课程中,培训社区合作伙伴通过资产分布图这一社区动员工具组建多元文化联盟。该课程既经济又高效,因为它使社区能够解决烟草控制以外的健康差异问题,如食品和营养、住房和环境问题。各联盟已做好准备,确定并提出建议,以解决导致健康差距长期存在的政策问题。对于倡导更严格烟草法规和政策的小型基层组织来说,与强大的烟草业巨头对抗是一项挑战。然而,这些组织对拯救黑人生命这一使命的热情和奉献精神能够推动变革。
{"title":"Strategies for Effective Capacity-Building in the Fight Against Commercial Tobacco.","authors":"Kimberly Caldwell, Ashley Hebert, Gregory Bolden","doi":"10.5888/pcd21.230307","DOIUrl":"10.5888/pcd21.230307","url":null,"abstract":"<p><p>The Center for Black Health & Equity's approach to addressing health inequities relies on the inherent ability within community-based organizations to respond to public health priorities while addressing the political and social determinants of health. By using Dr. Robert Robinson's Community Development Model as a foundational framework, communities can address systemic barriers that impede optimal health outcomes. The model includes community engagement and mobilization activities that motivate communities to achieve equity-centered policy change and offers milestones that show progress made toward their goals and objectives. We operationalized the Community Development Model into the Community Capacity Building Curriculum to train community partners to form a multicultural coalition through asset mapping as a tool for community mobilization. This curriculum is both cost effective and efficient because it enables communities to address health disparities beyond tobacco control, such as food and nutrition, housing, and environmental issues. Coalitions are prepared to identify and make recommendations to address policies that perpetuate health disparities. Facing off against a powerful tobacco industry giant is challenging for small grassroots organizations advocating for stricter tobacco regulations and policies. Such organizations struggle for resources; however, their passion and dedication to the mission of saving Black lives can promote change.</p>","PeriodicalId":51273,"journal":{"name":"Preventing Chronic Disease","volume":null,"pages":null},"PeriodicalIF":4.4,"publicationDate":"2024-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11155681/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141086767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Cost of Medications at a Student-Run Free Clinic in New Haven, Connecticut, 2021-2023. 2021-2023 年康涅狄格州纽黑文由学生运营的免费诊所的药物成本。
IF 5.5 3区 医学 Q1 Medicine Pub Date : 2024-05-16 DOI: 10.5888/pcd21.230277
Claudia See, Krupa Hegde, Lucy Reid, Ryan Shi, Ragini Luthra, Weilai Dong, Viola Lee, Angela Kang-Giaimo
IntroductionHaven is a student-run free clinic in New Haven, Connecticut, that serves more than 500 patients annually. Haven's pharmacy department helps patients obtain medications by providing discount coupons or medications from the clinic's in-house pharmacy, directly paying for medications at local pharmacies, and delivering medications to patients' homes. This study aimed to identify prescriptions that have the highest cost among Haven patients.MethodsOur sample consisted of all Haven patients who attended the clinic from March 2021 through March 2023. Patients were eligible to be seen at Haven if they were aged 18 to 65 years, lacked health insurance, and lived in New Haven. We determined the lowest cost of each medication prescribed to Haven patients by comparing prices among local pharmacies after applying a GoodRx discount. We defined expensive medication as more than $20 per prescription. We excluded medical supplies.ResultsOf the 594 Haven patients in our sample, 64% (n = 378) required financial assistance and 22% (n = 129) were prescribed at least 1 expensive medication. Among 129 patients prescribed an expensive medication, the mean (SD) age was 45.0 (12.3) years; 65% were women, and 87% were Hispanic or Latino. Median (IQR) household annual income was $14,400 [$0-$24,000]. We identified 246 expensive medications; the median (IQR) price per prescription was $31.43 ($24.00-$52.02). The most frequently prescribed expensive medications were fluticasone propionate/salmeterol (accounting for 6% of all expensive medications), medroxyprogesterone acetate (6%), albuterol sulfate (5%), and rosuvastatin (5%).ConclusionThe average Haven patient has an income well below the federal poverty level, and many have chronic cardiovascular and respiratory conditions that require expensive medications. Future research should work toward making medications universally affordable.
简介:Haven 是康涅狄格州纽黑文的一家由学生运营的免费诊所,每年为 500 多名患者提供服务。Haven 的药房部门通过提供折扣券或诊所内部药房的药物、直接支付当地药房的药费以及将药物送到患者家中等方式帮助患者获得药物。本研究旨在找出海文患者中费用最高的处方。方法我们的样本包括 2021 年 3 月至 2023 年 3 月期间在诊所就诊的所有海文患者。年龄在 18 岁至 65 岁之间、没有医疗保险且居住在纽黑文的患者均有资格在 Haven 就诊。我们通过比较当地药房的价格,在扣除 GoodRx 折扣后,确定了开给 Haven 患者的每种药物的最低成本。我们将每张处方超过 20 美元的药物定义为昂贵药物。在抽样调查的 594 名 Haven 患者中,64%(n = 378)需要经济援助,22%(n = 129)至少处方了一种昂贵的药物。在开具昂贵药物处方的 129 名患者中,平均(标清)年龄为 45.0 (12.3) 岁;65% 为女性,87% 为西班牙裔或拉丁裔。家庭年收入中位数(IQR)为 14,400 美元[0-24,000 美元]。我们发现了 246 种昂贵的药物;每张处方的中位数(IQR)价格为 31.43 美元(24.00-52.02 美元)。最常处方的昂贵药物是丙酸氟替卡松/沙美特罗(占所有昂贵药物的 6%)、醋酸甲羟孕酮(6%)、硫酸阿布特罗(5%)和洛伐他汀(5%)。未来的研究应致力于让所有人都能买得起药。
{"title":"The Cost of Medications at a Student-Run Free Clinic in New Haven, Connecticut, 2021-2023.","authors":"Claudia See, Krupa Hegde, Lucy Reid, Ryan Shi, Ragini Luthra, Weilai Dong, Viola Lee, Angela Kang-Giaimo","doi":"10.5888/pcd21.230277","DOIUrl":"https://doi.org/10.5888/pcd21.230277","url":null,"abstract":"Introduction\u0000Haven is a student-run free clinic in New Haven, Connecticut, that serves more than 500 patients annually. Haven's pharmacy department helps patients obtain medications by providing discount coupons or medications from the clinic's in-house pharmacy, directly paying for medications at local pharmacies, and delivering medications to patients' homes. This study aimed to identify prescriptions that have the highest cost among Haven patients.\u0000\u0000\u0000Methods\u0000Our sample consisted of all Haven patients who attended the clinic from March 2021 through March 2023. Patients were eligible to be seen at Haven if they were aged 18 to 65 years, lacked health insurance, and lived in New Haven. We determined the lowest cost of each medication prescribed to Haven patients by comparing prices among local pharmacies after applying a GoodRx discount. We defined expensive medication as more than $20 per prescription. We excluded medical supplies.\u0000\u0000\u0000Results\u0000Of the 594 Haven patients in our sample, 64% (n = 378) required financial assistance and 22% (n = 129) were prescribed at least 1 expensive medication. Among 129 patients prescribed an expensive medication, the mean (SD) age was 45.0 (12.3) years; 65% were women, and 87% were Hispanic or Latino. Median (IQR) household annual income was $14,400 [$0-$24,000]. We identified 246 expensive medications; the median (IQR) price per prescription was $31.43 ($24.00-$52.02). The most frequently prescribed expensive medications were fluticasone propionate/salmeterol (accounting for 6% of all expensive medications), medroxyprogesterone acetate (6%), albuterol sulfate (5%), and rosuvastatin (5%).\u0000\u0000\u0000Conclusion\u0000The average Haven patient has an income well below the federal poverty level, and many have chronic cardiovascular and respiratory conditions that require expensive medications. Future research should work toward making medications universally affordable.","PeriodicalId":51273,"journal":{"name":"Preventing Chronic Disease","volume":null,"pages":null},"PeriodicalIF":5.5,"publicationDate":"2024-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140968358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Homeownership Matters: Impact of Homeownership on the Prevalence of Chronic Health Conditions in the United States. 房屋所有权很重要:房屋所有权对美国慢性病患病率的影响》(Homeownership Matters: Impact of Homeownership on the Prevalence of Chronic Health Conditions in the United States)。
IF 5.5 3区 医学 Q1 Medicine Pub Date : 2024-05-16 DOI: 10.5888/pcd21.230324
Shams Rahman, David Steeb
IntroductionHomeownership is crucial for stability and healthy life. We examined the role of homeownership in predicting the prevalence of common chronic health conditions in the United States.MethodsWe used 2020 Behavioral Risk Factor Surveillance System data (N = 401,958) to assess the association between homeownership and self-reported diagnosed diabetes, asthma, cancer, coronary heart disease (CHD), stroke, and kidney disease. We analyzed data by using logistic regression, adjusting for age, sex, race and ethnicity, education, employment, and income and computed odds ratios (ORs) and corresponding 95% CIs.ResultsMost survey participants (66.8%) owned their residences. Age, marital status, education, and income significantly influenced homeownership. Odds of homeownership progressively increased with age, reaching a peak at 17.45 (95% CI, 16.21-18.79) for adults aged 65 years or older, and non-Hispanic White adults had the highest odds (OR = 3.34; 95% CI, 3.18-3.52). Compared with renters, homeowners generally had lower prevalence of chronic health conditions, especially among those aged 45 to 64 years. After adjusting for age, sex, and race and ethnicity, the odds of having chronic health conditions among renters were higher than those of homeowners: CHD, 1.39 (1.27-1.52); diabetes, 1.27 (1.20-1.35); asthma, 1.29 (1.23-1.36); stroke, 1.89 (1.71-2.09); and kidney disease, 1.59 (1.44-1.77).ConclusionHomeownership can be used to predict the prevalence of several chronic health conditions. Considering its significant influence, public health initiatives should focus on housing-related interventions to improve population health.
导言:拥有住房对稳定和健康的生活至关重要。我们利用 2020 年行为风险因素监测系统数据(N = 401,958 人)评估了房屋所有权与自我报告的糖尿病、哮喘、癌症、冠心病(CHD)、中风和肾病之间的关系。我们使用逻辑回归法分析数据,并对年龄、性别、种族和民族、教育、就业和收入进行了调整,计算出了几率比(OR)和相应的 95% CI。年龄、婚姻状况、教育程度和收入对房屋所有权有显著影响。随着年龄的增长,拥有住房的几率逐渐增加,65 岁或以上的成年人拥有住房的几率最高,为 17.45(95% CI,16.21-18.79),非西班牙裔白人拥有住房的几率最高(OR = 3.34;95% CI,3.18-3.52)。与租房者相比,房主的慢性病患病率普遍较低,尤其是在 45 至 64 岁的人群中。在对年龄、性别、种族和民族进行调整后,租房者患有慢性病的几率高于房主:结论:房主身份可用于预测多种慢性疾病的患病率。考虑到其重大影响,公共卫生措施应侧重于与住房相关的干预措施,以改善人口健康。
{"title":"Homeownership Matters: Impact of Homeownership on the Prevalence of Chronic Health Conditions in the United States.","authors":"Shams Rahman, David Steeb","doi":"10.5888/pcd21.230324","DOIUrl":"https://doi.org/10.5888/pcd21.230324","url":null,"abstract":"Introduction\u0000Homeownership is crucial for stability and healthy life. We examined the role of homeownership in predicting the prevalence of common chronic health conditions in the United States.\u0000\u0000\u0000Methods\u0000We used 2020 Behavioral Risk Factor Surveillance System data (N = 401,958) to assess the association between homeownership and self-reported diagnosed diabetes, asthma, cancer, coronary heart disease (CHD), stroke, and kidney disease. We analyzed data by using logistic regression, adjusting for age, sex, race and ethnicity, education, employment, and income and computed odds ratios (ORs) and corresponding 95% CIs.\u0000\u0000\u0000Results\u0000Most survey participants (66.8%) owned their residences. Age, marital status, education, and income significantly influenced homeownership. Odds of homeownership progressively increased with age, reaching a peak at 17.45 (95% CI, 16.21-18.79) for adults aged 65 years or older, and non-Hispanic White adults had the highest odds (OR = 3.34; 95% CI, 3.18-3.52). Compared with renters, homeowners generally had lower prevalence of chronic health conditions, especially among those aged 45 to 64 years. After adjusting for age, sex, and race and ethnicity, the odds of having chronic health conditions among renters were higher than those of homeowners: CHD, 1.39 (1.27-1.52); diabetes, 1.27 (1.20-1.35); asthma, 1.29 (1.23-1.36); stroke, 1.89 (1.71-2.09); and kidney disease, 1.59 (1.44-1.77).\u0000\u0000\u0000Conclusion\u0000Homeownership can be used to predict the prevalence of several chronic health conditions. Considering its significant influence, public health initiatives should focus on housing-related interventions to improve population health.","PeriodicalId":51273,"journal":{"name":"Preventing Chronic Disease","volume":null,"pages":null},"PeriodicalIF":5.5,"publicationDate":"2024-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140968220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Homeownership Matters: Impact of Homeownership on the Prevalence of Chronic Health Conditions in the United States. 房屋所有权很重要:房屋所有权对美国慢性病患病率的影响》(Homeownership Matters: Impact of Homeownership on the Prevalence of Chronic Health Conditions in the United States)。
IF 5.5 3区 医学 Q1 Medicine Pub Date : 2024-05-16 DOI: 10.5888/pcd21.230324
Shams Rahman, David Steeb

Introduction: Homeownership is crucial for stability and healthy life. We examined the role of homeownership in predicting the prevalence of common chronic health conditions in the United States.

Methods: We used 2020 Behavioral Risk Factor Surveillance System data (N = 401,958) to assess the association between homeownership and self-reported diagnosed diabetes, asthma, cancer, coronary heart disease (CHD), stroke, and kidney disease. We analyzed data by using logistic regression, adjusting for age, sex, race and ethnicity, education, employment, and income and computed odds ratios (ORs) and corresponding 95% CIs.

Results: Most survey participants (66.8%) owned their residences. Age, marital status, education, and income significantly influenced homeownership. Odds of homeownership progressively increased with age, reaching a peak at 17.45 (95% CI, 16.21-18.79) for adults aged 65 years or older, and non-Hispanic White adults had the highest odds (OR = 3.34; 95% CI, 3.18-3.52). Compared with renters, homeowners generally had lower prevalence of chronic health conditions, especially among those aged 45 to 64 years. After adjusting for age, sex, and race and ethnicity, the odds of having chronic health conditions among renters were higher than those of homeowners: CHD, 1.39 (1.27-1.52); diabetes, 1.27 (1.20-1.35); asthma, 1.29 (1.23-1.36); stroke, 1.89 (1.71-2.09); and kidney disease, 1.59 (1.44-1.77).

Conclusion: Homeownership can be used to predict the prevalence of several chronic health conditions. Considering its significant influence, public health initiatives should focus on housing-related interventions to improve population health.

介绍:拥有住房对稳定和健康的生活至关重要。我们研究了房屋所有权在预测美国常见慢性病患病率方面的作用:我们利用 2020 年行为风险因素监测系统数据(N = 401,958 人)评估了房屋所有权与自我报告的糖尿病、哮喘、癌症、冠心病(CHD)、中风和肾病之间的关系。我们使用逻辑回归法分析了数据,并对年龄、性别、种族和民族、教育程度、就业和收入进行了调整,计算了几率比(ORs)和相应的 95% CIs:大多数调查参与者(66.8%)拥有自己的住宅。年龄、婚姻状况、教育程度和收入对房屋所有权有显著影响。随着年龄的增长,拥有住房的几率逐渐增加,65 岁或以上的成年人拥有住房的几率最高,为 17.45(95% CI,16.21-18.79),非西班牙裔白人拥有住房的几率最高(OR = 3.34;95% CI,3.18-3.52)。与租房者相比,房主的慢性病患病率普遍较低,尤其是在 45 至 64 岁的人群中。在对年龄、性别、种族和民族进行调整后,租房者患有慢性病的几率高于房主:冠心病,1.39(1.27-1.52);糖尿病,1.27(1.20-1.35);哮喘,1.29(1.23-1.36);中风,1.89(1.71-2.09);肾病,1.59(1.44-1.77):结论:房屋所有权可用于预测几种慢性疾病的患病率。考虑到其重大影响,公共卫生措施应侧重于与住房相关的干预措施,以改善人口健康。
{"title":"Homeownership Matters: Impact of Homeownership on the Prevalence of Chronic Health Conditions in the United States.","authors":"Shams Rahman, David Steeb","doi":"10.5888/pcd21.230324","DOIUrl":"10.5888/pcd21.230324","url":null,"abstract":"<p><strong>Introduction: </strong>Homeownership is crucial for stability and healthy life. We examined the role of homeownership in predicting the prevalence of common chronic health conditions in the United States.</p><p><strong>Methods: </strong>We used 2020 Behavioral Risk Factor Surveillance System data (N = 401,958) to assess the association between homeownership and self-reported diagnosed diabetes, asthma, cancer, coronary heart disease (CHD), stroke, and kidney disease. We analyzed data by using logistic regression, adjusting for age, sex, race and ethnicity, education, employment, and income and computed odds ratios (ORs) and corresponding 95% CIs.</p><p><strong>Results: </strong>Most survey participants (66.8%) owned their residences. Age, marital status, education, and income significantly influenced homeownership. Odds of homeownership progressively increased with age, reaching a peak at 17.45 (95% CI, 16.21-18.79) for adults aged 65 years or older, and non-Hispanic White adults had the highest odds (OR = 3.34; 95% CI, 3.18-3.52). Compared with renters, homeowners generally had lower prevalence of chronic health conditions, especially among those aged 45 to 64 years. After adjusting for age, sex, and race and ethnicity, the odds of having chronic health conditions among renters were higher than those of homeowners: CHD, 1.39 (1.27-1.52); diabetes, 1.27 (1.20-1.35); asthma, 1.29 (1.23-1.36); stroke, 1.89 (1.71-2.09); and kidney disease, 1.59 (1.44-1.77).</p><p><strong>Conclusion: </strong>Homeownership can be used to predict the prevalence of several chronic health conditions. Considering its significant influence, public health initiatives should focus on housing-related interventions to improve population health.</p>","PeriodicalId":51273,"journal":{"name":"Preventing Chronic Disease","volume":null,"pages":null},"PeriodicalIF":5.5,"publicationDate":"2024-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11155682/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140960128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Cost of Medications at a Student-Run Free Clinic in New Haven, Connecticut, 2021-2023. 2021-2023 年康涅狄格州纽黑文由学生运营的免费诊所的药物成本。
IF 5.5 3区 医学 Q1 Medicine Pub Date : 2024-05-16 DOI: 10.5888/pcd21.230277
Claudia See, Krupa Hegde, Lucy Reid, Ryan Shi, Ragini Luthra, Weilai Dong, Viola Lee, Angela Kang-Giaimo

Introduction: Haven is a student-run free clinic in New Haven, Connecticut, that serves more than 500 patients annually. Haven's pharmacy department helps patients obtain medications by providing discount coupons or medications from the clinic's in-house pharmacy, directly paying for medications at local pharmacies, and delivering medications to patients' homes. This study aimed to identify prescriptions that have the highest cost among Haven patients.

Methods: Our sample consisted of all Haven patients who attended the clinic from March 2021 through March 2023. Patients were eligible to be seen at Haven if they were aged 18 to 65 years, lacked health insurance, and lived in New Haven. We determined the lowest cost of each medication prescribed to Haven patients by comparing prices among local pharmacies after applying a GoodRx discount. We defined expensive medication as more than $20 per prescription. We excluded medical supplies.

Results: Of the 594 Haven patients in our sample, 64% (n = 378) required financial assistance and 22% (n = 129) were prescribed at least 1 expensive medication. Among 129 patients prescribed an expensive medication, the mean (SD) age was 45.0 (12.3) years; 65% were women, and 87% were Hispanic or Latino. Median (IQR) household annual income was $14,400 [$0-$24,000]. We identified 246 expensive medications; the median (IQR) price per prescription was $31.43 ($24.00-$52.02). The most frequently prescribed expensive medications were fluticasone propionate/salmeterol (accounting for 6% of all expensive medications), medroxyprogesterone acetate (6%), albuterol sulfate (5%), and rosuvastatin (5%).

Conclusion: The average Haven patient has an income well below the federal poverty level, and many have chronic cardiovascular and respiratory conditions that require expensive medications. Future research should work toward making medications universally affordable.

简介Haven 是康涅狄格州纽黑文的一家由学生经营的免费诊所,每年为 500 多名患者提供服务。Haven 的药房部门通过提供折扣券或诊所内部药房的药物、直接支付当地药房的药费以及将药物送到患者家中等方式帮助患者获得药物。本研究旨在确定海文患者中费用最高的处方:我们的样本包括 2021 年 3 月至 2023 年 3 月期间就诊的所有 Haven 患者。年龄在 18 岁至 65 岁之间、没有医疗保险且居住在纽黑文的患者均有资格在 Haven 就诊。我们通过比较当地药房的价格,在扣除 GoodRx 折扣后,确定了开给 Haven 患者的每种药物的最低成本。我们将每张处方超过 20 美元的药物定义为昂贵药物。我们将医疗用品排除在外:在样本中的 594 名 Haven 患者中,64%(n = 378)需要经济援助,22%(n = 129)至少处方了一种昂贵的药物。在开具昂贵药物处方的 129 名患者中,平均(标清)年龄为 45.0 (12.3) 岁;65% 为女性,87% 为西班牙裔或拉丁裔。家庭年收入中位数(IQR)为 14,400 美元[0-24,000 美元]。我们发现了 246 种昂贵的药物;每张处方的中位数(IQR)价格为 31.43 美元(24.00-52.02 美元)。最常处方的昂贵药物是丙酸氟替卡松/沙美特罗(占所有昂贵药物的 6%)、醋酸甲羟孕酮(6%)、硫酸阿布特罗(5%)和洛伐他汀(5%):结论:哈文病人的平均收入远低于联邦贫困线,许多人患有慢性心血管和呼吸系统疾病,需要服用昂贵的药物。未来的研究应致力于让所有人都能买得起药。
{"title":"The Cost of Medications at a Student-Run Free Clinic in New Haven, Connecticut, 2021-2023.","authors":"Claudia See, Krupa Hegde, Lucy Reid, Ryan Shi, Ragini Luthra, Weilai Dong, Viola Lee, Angela Kang-Giaimo","doi":"10.5888/pcd21.230277","DOIUrl":"10.5888/pcd21.230277","url":null,"abstract":"<p><strong>Introduction: </strong>Haven is a student-run free clinic in New Haven, Connecticut, that serves more than 500 patients annually. Haven's pharmacy department helps patients obtain medications by providing discount coupons or medications from the clinic's in-house pharmacy, directly paying for medications at local pharmacies, and delivering medications to patients' homes. This study aimed to identify prescriptions that have the highest cost among Haven patients.</p><p><strong>Methods: </strong>Our sample consisted of all Haven patients who attended the clinic from March 2021 through March 2023. Patients were eligible to be seen at Haven if they were aged 18 to 65 years, lacked health insurance, and lived in New Haven. We determined the lowest cost of each medication prescribed to Haven patients by comparing prices among local pharmacies after applying a GoodRx discount. We defined expensive medication as more than $20 per prescription. We excluded medical supplies.</p><p><strong>Results: </strong>Of the 594 Haven patients in our sample, 64% (n = 378) required financial assistance and 22% (n = 129) were prescribed at least 1 expensive medication. Among 129 patients prescribed an expensive medication, the mean (SD) age was 45.0 (12.3) years; 65% were women, and 87% were Hispanic or Latino. Median (IQR) household annual income was $14,400 [$0-$24,000]. We identified 246 expensive medications; the median (IQR) price per prescription was $31.43 ($24.00-$52.02). The most frequently prescribed expensive medications were fluticasone propionate/salmeterol (accounting for 6% of all expensive medications), medroxyprogesterone acetate (6%), albuterol sulfate (5%), and rosuvastatin (5%).</p><p><strong>Conclusion: </strong>The average Haven patient has an income well below the federal poverty level, and many have chronic cardiovascular and respiratory conditions that require expensive medications. Future research should work toward making medications universally affordable.</p>","PeriodicalId":51273,"journal":{"name":"Preventing Chronic Disease","volume":null,"pages":null},"PeriodicalIF":5.5,"publicationDate":"2024-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11155686/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140960129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk of Chronic Obstructive Pulmonary Disease and Receipt of a Breathing Test in 26 States and the District of Columbia, 2017-2018. 2017-2018 年 26 个州和哥伦比亚特区的慢性阻塞性肺病风险和接受呼吸测试的情况。
IF 5.5 3区 医学 Q1 Medicine Pub Date : 2024-05-09 DOI: 10.5888/pcd21.230399
Kathleen B Watson, Janet B Croft, Anne G Wheaton, Yong Liu, Antonello Punturieri, Lisa Postow, Susan A Carlson, Kurt J Greenlund

We estimated the prevalence of respiratory symptoms, chronic obstructive pulmonary disease (COPD) risk level, and receipt of a breathing test among adults without reported COPD in 26 states and the District of Columbia by using 2017-2018 Behavioral Risk Factor Surveillance System data. Among adults without reported COPD, the 3 respiratory symptoms indicating COPD (chronic cough, phlegm or mucus production, shortness of breath) were common (each >10%). About 15.0% were at higher COPD risk (based on the number of symptoms, age, and smoking status); 41.4% of adults at higher risk reported receipt of a breathing test. Patient-provider recognition and communication of risk symptoms, appropriate screening, and follow-up are important for early diagnosis and treatment.

我们利用 2017-2018 年行为风险因素监测系统数据,估算了 26 个州和哥伦比亚特区未报告慢性阻塞性肺病(COPD)的成年人中呼吸道症状、慢性阻塞性肺病(COPD)风险水平和接受呼吸测试的流行率。在未报告患有慢性阻塞性肺病的成年人中,表明患有慢性阻塞性肺病的 3 种呼吸道症状(慢性咳嗽、痰或粘液分泌、呼吸急促)很常见(均大于 10%)。约 15.0% 的人患有慢性阻塞性肺病的风险较高(基于症状数量、年龄和吸烟状况);41.4% 的高风险成人报告接受过呼吸测试。患者和医护人员对风险症状的识别和沟通、适当的筛查和随访对早期诊断和治疗非常重要。
{"title":"Risk of Chronic Obstructive Pulmonary Disease and Receipt of a Breathing Test in 26 States and the District of Columbia, 2017-2018.","authors":"Kathleen B Watson, Janet B Croft, Anne G Wheaton, Yong Liu, Antonello Punturieri, Lisa Postow, Susan A Carlson, Kurt J Greenlund","doi":"10.5888/pcd21.230399","DOIUrl":"10.5888/pcd21.230399","url":null,"abstract":"<p><p>We estimated the prevalence of respiratory symptoms, chronic obstructive pulmonary disease (COPD) risk level, and receipt of a breathing test among adults without reported COPD in 26 states and the District of Columbia by using 2017-2018 Behavioral Risk Factor Surveillance System data. Among adults without reported COPD, the 3 respiratory symptoms indicating COPD (chronic cough, phlegm or mucus production, shortness of breath) were common (each >10%). About 15.0% were at higher COPD risk (based on the number of symptoms, age, and smoking status); 41.4% of adults at higher risk reported receipt of a breathing test. Patient-provider recognition and communication of risk symptoms, appropriate screening, and follow-up are important for early diagnosis and treatment.</p>","PeriodicalId":51273,"journal":{"name":"Preventing Chronic Disease","volume":null,"pages":null},"PeriodicalIF":5.5,"publicationDate":"2024-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11086692/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140900335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Geographic Disparities in Cancer Incidence in the US Population Aged 20 to 49 Years, 2016-2020. 2016-2020 年美国 20 至 49 岁人口癌症发病率的地域差异。
IF 5.5 3区 医学 Q1 Medicine Pub Date : 2024-05-09 DOI: 10.5888/pcd21.230335
Tesla D DuBois, Kevin A Henry, Scott D Siegel, Shannon M Lynch
{"title":"Geographic Disparities in Cancer Incidence in the US Population Aged 20 to 49 Years, 2016-2020.","authors":"Tesla D DuBois, Kevin A Henry, Scott D Siegel, Shannon M Lynch","doi":"10.5888/pcd21.230335","DOIUrl":"10.5888/pcd21.230335","url":null,"abstract":"","PeriodicalId":51273,"journal":{"name":"Preventing Chronic Disease","volume":null,"pages":null},"PeriodicalIF":5.5,"publicationDate":"2024-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11086694/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140900367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Community Engagement, Jurisdictional Experience, and Previous Tobacco-Related Ordinances in Neighboring Communities as Drivers of Flavored Tobacco Bans in Los Angeles County. 社区参与、辖区经验以及邻近社区以前的烟草相关法令是洛杉矶县香烟禁令的驱动因素。
IF 5.5 3区 医学 Q1 Medicine Pub Date : 2024-05-02 DOI: 10.5888/pcd21.230284
Dana Guglielmo, Andy Dang, Lori Fischbach, Ruth Toruno, Gladis Chavez-Sosa, Montgomery Messex, Tonya Gorham Gallow, Claud Moradian, Tony Kuo

We examined whether a community engagement approach and jurisdictional attributes were associated with local action to restrict the sale of flavored tobacco products in Los Angeles County during 2019-2022. We estimated crude and adjusted risk ratios to examine these associations. Jurisdictions that used an active community engagement approach to adopt a flavored tobacco ban ordinance, those with previous experience adopting other tobacco-related ordinances, and those located next to communities that have an existing tobacco retail license ordinance were more likely than jurisdictions without these attributes to adopt a new ordinance to restrict the sale of flavored tobacco products. Efforts to adopt such an ordinance were generally more successful in jurisdictions where community members were engaged and policy makers were familiar with the adoption of public health ordinances.

我们研究了在 2019-2022 年期间,社区参与方式和辖区属性是否与洛杉矶县限制销售调味烟草制品的地方行动有关。我们估算了粗略风险比和调整风险比,以研究这些关联。采用积极的社区参与方式来通过禁止香烟法令的辖区、以前有过通过其他烟草相关法令经验的辖区以及与现有烟草零售许可法令的社区相邻的辖区比不具备这些属性的辖区更有可能通过新法令来限制香烟产品的销售。在社区成员参与、政策制定者熟悉公共卫生条例制定的辖区,通过此类条例的努力通常更为成功。
{"title":"Community Engagement, Jurisdictional Experience, and Previous Tobacco-Related Ordinances in Neighboring Communities as Drivers of Flavored Tobacco Bans in Los Angeles County.","authors":"Dana Guglielmo, Andy Dang, Lori Fischbach, Ruth Toruno, Gladis Chavez-Sosa, Montgomery Messex, Tonya Gorham Gallow, Claud Moradian, Tony Kuo","doi":"10.5888/pcd21.230284","DOIUrl":"10.5888/pcd21.230284","url":null,"abstract":"<p><p>We examined whether a community engagement approach and jurisdictional attributes were associated with local action to restrict the sale of flavored tobacco products in Los Angeles County during 2019-2022. We estimated crude and adjusted risk ratios to examine these associations. Jurisdictions that used an active community engagement approach to adopt a flavored tobacco ban ordinance, those with previous experience adopting other tobacco-related ordinances, and those located next to communities that have an existing tobacco retail license ordinance were more likely than jurisdictions without these attributes to adopt a new ordinance to restrict the sale of flavored tobacco products. Efforts to adopt such an ordinance were generally more successful in jurisdictions where community members were engaged and policy makers were familiar with the adoption of public health ordinances.</p>","PeriodicalId":51273,"journal":{"name":"Preventing Chronic Disease","volume":null,"pages":null},"PeriodicalIF":5.5,"publicationDate":"2024-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11086693/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140856887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Costs and Projected Effect of a Federally Qualified Health Center-Based Mailed Colorectal Cancer Screening Program in Texas. 德克萨斯州联邦合格医疗中心邮寄大肠癌筛查计划的成本和预期效果。
IF 5.5 3区 医学 Q1 Medicine Pub Date : 2024-05-02 DOI: 10.5888/pcd21.230266
Todd Olmstead, Jennifer C Spencer, Nicole Kluz, F Benjamin Zhan, Navkiran K Shokar, Michael Pignone

Introduction: Mailed stool testing for colorectal cancer (CRC) may improve screening uptake and reduce the incidence and mortality of CRC, especially among patients at federally qualified health centers (FQHCs). To expand screening programs it is important to identify cost-effective approaches.

Methods: We developed a decision-analytic model to estimate the cost, effects on screening and patient outcomes (CRCs detected, CRCs prevented, CRC deaths prevented), and cost-effectiveness of implementing a state-wide mailed stool testing program over 5 years among unscreened, age-eligible (aged 50-75 y) patients at FQHCs in Texas. We compared various outreach strategies and organizational structures (centralized, regional, or a hybrid). We used data from our existing regional mailed stool testing program and recent systematic reviews to set parameters for the model. Costs included start-up and ongoing activities and were estimated in 2022 US dollars from the perspective of a hypothetical third-party payer. Cost-effectiveness was assessed by using both incremental and average cost-effectiveness ratios.

Results: Using either a statewide centralized or hybrid organizational configuration to mail stool tests to newly eligible FQHC patients and patients who have responded at least once since program inception is likely to result in the best use of resources over 5 years, enabling more than 110,000 additional screens, detecting an incremental 181 to 194 CRCs, preventing 91 to 98 CRCs, and averting 46 to 50 CRC deaths, at a cost of $10 million to $11 million compared with no program.

Conclusions: A statewide mailed stool testing program for FQHC patients can be implemented at reasonable cost with considerable effects on CRC screening outcomes, especially when its structure maximizes program efficiency while maintaining effectiveness.

导言:针对结直肠癌(CRC)的邮寄粪便检测可提高筛查率,降低 CRC 的发病率和死亡率,尤其是在联邦合格医疗中心(FQHC)的患者中。为了扩大筛查项目,必须确定具有成本效益的方法:我们建立了一个决策分析模型,以估算成本、对筛查和患者结果(发现的 CRC、预防的 CRC、预防的 CRC 死亡)的影响,以及在得克萨斯州联邦合格健康中心未接受筛查、符合年龄要求(50-75 岁)的患者中实施为期 5 年的全州邮寄粪便检测计划的成本效益。我们比较了各种推广策略和组织结构(集中式、区域式或混合式)。我们利用现有的地区性邮寄粪便检测项目的数据和近期的系统综述来设定模型参数。成本包括启动成本和持续活动成本,并从假设的第三方付款人的角度以 2022 年美元估算。成本效益采用增量成本效益比和平均成本效益比进行评估:结果:采用全州集中式或混合式组织配置,向新近符合条件的 FQHC 患者和自计划启动以来至少回复过一次的患者邮寄粪便检测试剂,可能会在 5 年内实现资源的最佳利用,使筛查人数增加 110,000 多人,检测出 181 至 194 例 CRC,预防 91 至 98 例 CRC,避免 46 至 50 例 CRC 死亡,与不实施计划相比,成本为 1,000 万至 1,100 万美元:全州范围内针对 FQHC 患者的邮寄粪便检测计划可以以合理的成本实施,并对 CRC 筛查结果产生相当大的影响,尤其是当其结构在保持有效性的同时最大限度地提高计划效率时。
{"title":"Costs and Projected Effect of a Federally Qualified Health Center-Based Mailed Colorectal Cancer Screening Program in Texas.","authors":"Todd Olmstead, Jennifer C Spencer, Nicole Kluz, F Benjamin Zhan, Navkiran K Shokar, Michael Pignone","doi":"10.5888/pcd21.230266","DOIUrl":"10.5888/pcd21.230266","url":null,"abstract":"<p><strong>Introduction: </strong>Mailed stool testing for colorectal cancer (CRC) may improve screening uptake and reduce the incidence and mortality of CRC, especially among patients at federally qualified health centers (FQHCs). To expand screening programs it is important to identify cost-effective approaches.</p><p><strong>Methods: </strong>We developed a decision-analytic model to estimate the cost, effects on screening and patient outcomes (CRCs detected, CRCs prevented, CRC deaths prevented), and cost-effectiveness of implementing a state-wide mailed stool testing program over 5 years among unscreened, age-eligible (aged 50-75 y) patients at FQHCs in Texas. We compared various outreach strategies and organizational structures (centralized, regional, or a hybrid). We used data from our existing regional mailed stool testing program and recent systematic reviews to set parameters for the model. Costs included start-up and ongoing activities and were estimated in 2022 US dollars from the perspective of a hypothetical third-party payer. Cost-effectiveness was assessed by using both incremental and average cost-effectiveness ratios.</p><p><strong>Results: </strong>Using either a statewide centralized or hybrid organizational configuration to mail stool tests to newly eligible FQHC patients and patients who have responded at least once since program inception is likely to result in the best use of resources over 5 years, enabling more than 110,000 additional screens, detecting an incremental 181 to 194 CRCs, preventing 91 to 98 CRCs, and averting 46 to 50 CRC deaths, at a cost of $10 million to $11 million compared with no program.</p><p><strong>Conclusions: </strong>A statewide mailed stool testing program for FQHC patients can be implemented at reasonable cost with considerable effects on CRC screening outcomes, especially when its structure maximizes program efficiency while maintaining effectiveness.</p>","PeriodicalId":51273,"journal":{"name":"Preventing Chronic Disease","volume":null,"pages":null},"PeriodicalIF":5.5,"publicationDate":"2024-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11086695/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140868726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Preventing Chronic Disease
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1